CDK6 and cancer: CDK6 is overexpressed in cancer cells but only detected at low levels in non-cancer cells and CDK6-null mice have been found to develop normally (11), suggesting a potential low-toxicity therapeutic strategy through the inhibition of the expression of CDK6.